A study of the effects of consumption of the test beverage on improvement of unidentified complaints associated with menstruatio
- Conditions
- Healthy adult female
- Registration Number
- JPRN-UMIN000053169
- Lead Sponsor
- everage Brain Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 60
Not provided
1)Subject who has serious disorders on brain, hepatic, kidney, cardiac, lung, digestive organs, blood, endocrine system, and metabolic system 2)Subject who is under medication on a steady basis or history of medication for serious disorders 3)Subject currently undergoing treatment or with digestive diseases that affect the study or have a surgical history of digestive system(except appendicectomy) 4)Subject with gynecological disorders (secondary amenorrhea, dysmenorrhea, endometriosis, uterine fibroids, premenstrual dysphoric disorder (PMDD), premenstrual syndrome (PMS), breast cancer, cervical cancer, uterine body cancer, ovarian cancer, etc.) 5)Subject who has difficulty drinking study beverage 6)Subject who takes medications and supplements on a daily basis *Except subject who can cancel an intake of health foods and supplements during this trial 7)Subject who has no menstrual discomfort symptoms at all, do not use over-the-counter pain relievers at all when symptoms are present, or whose symptoms are severe and cannot be controlled with over-the-counter pain relievers. 8)Subject who is pregnant, lactating mother, or who is willing to become pregnant during this trial 9)Any candidates considered to be ineligible for enrollment due to the results of health condition questionnaire 10)Subject who took part in the other clinical/monitoring trial within a month before giving informed consent to take part in this trial. 11)Subject with area IV on the Neuroticism Discriminant Chart of the CMI Health Questionnaire 12)Those whose total score on the Postmenstrual Associated Symptom Questionnaire is 0 points or higher than the total score on the Premenstrual Associated Symptom Questionnaire or the total score on the Menstrual Associated Symptom Questionnaire during menstruation, regarding the Menstrual Associated Symptoms Questionnaire (pre-survey). 13)Any candidates considered to be unsuitable for enrollment in the opinion of the principal investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method